🏷

Classifications

Harrison's Part

ISDS Skeletal Nosology

👪

Inheritance

1

Sporadic occurrence, inheritance unresolved

Almost all reported cases are sporadic. No inheritance mode is established, and the ISDS Nosology prints none. A genetic basis is suspected but not demonstrated.

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"Around 200 patients have been reported and almost all cases have been sporadic."

Sporadic occurrence is what the literature reports; no mode of inheritance is asserted here because none is established.

?

Discussions and Knowledge Gaps

1

Is Hallermann-Streiff syndrome one disease? If the original reports described patients with heterogeneous conditions, what fraction of the ~200 published cases would a molecular diagnosis reassign to some other entity?

KNOWLEDGE GAP hss_entity_heterogeneity

Attached to

pathophysiology#Unresolved Etiology

This is a gap about the entity, not only about its mechanism. A 2026 review concludes that the phenotype is consistent but that the original reports likely described heterogeneous conditions, and that HSS overlaps clinically with other genetic conditions - osteocraniostenosis among them. Without a genetic test, there is no way to tell a true HSS case from a phenocopy, so any mechanism curated for "HSS" risks being a mechanism for whatever mixture the label currently denotes.

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"It is also likely that the original reports of HSS described patients with heterogeneous conditions."

The review's own statement that the diagnostic category may not be a single entity.

⚙

Pathophysiology

1

Unresolved Etiology

No mechanism is known. HSS is suspected to have a genetic basis, and non-recurrent deleterious variants in GJA1, CHD6 and ZMPSTE24 have been noted in individuals carrying the diagnosis, but none recurs across patients and the etiology of almost all cases remains unknown. There is no genetic test and no biomarker, which has itself hampered accurate delineation of the condition. This node exists to record the gap explicitly rather than to leave the pathophysiology section empty or to promote a candidate gene to a causal claim it cannot support.

Downstream

Congenital cataracts One of the seven cardinal findings. Attached to the etiology node because no mechanism is known - the edge records that the feature belongs to the entity, not that a mechanism explains it.

Microphthalmia One of the seven cardinal findings; see the caveat on the cataract edge.

Recognizable facial features One of the seven cardinal findings; see the caveat on the cataract edge.

Sparse hair with hypotrichosis One of the seven cardinal findings; see the caveat on the cataract edge.

Skin atrophy One of the seven cardinal findings; see the caveat on the cataract edge.

Dental anomalies One of the seven cardinal findings; see the caveat on the cataract edge.

Short stature One of the seven cardinal findings, and what places the disorder in this nosology group; see the caveat on the cataract edge.

Micrognathia Part of the craniofacial gestalt, and the anatomical basis of the airway obstruction below.

Midface hypoplasia Part of the craniofacial gestalt, and with the micrognathia the anatomical basis of the airway obstruction.

Progeroid features Attached here on the same basis as the cardinal findings - the association is recognized, no mechanism is known. Worth noting that one of the three candidate genes named on this node, ZMPSTE24, causes laminopathies with premature aging, so the progeroid overlap is the feature that has most often motivated candidate-gene work.

Natal teeth A specific instance of the dental anomalies already attached here; the same caveat applies - the edge records membership, not a mechanism.

Show evidence (2 references)

PMID:41742277 SUPPORT Human Clinical

"Although HSS is suspected to have a genetic basis and non-recurrent deleterious variants in genes such as GJA1, CHD6, and ZMPSTE24 have been noted in patients diagnosed with HSS, the etiology for almost all cases remains unknown."

States both the candidate genes and the fact that they do not amount to an etiology, which is exactly the claim this node makes.

PMID:41742277 SUPPORT Human Clinical

"the lack of a genetic test or other biomarker has complicated an accurate delineation of the condition"

Explains why the entity itself, not just its mechanism, is imprecisely defined.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

13

Eye 2

Congenital cataracts VERY_FREQUENT Developmental cataract HP:0000519

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"characterized by seven cardinal findings comprising congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature"

One of the seven cardinal findings that define the syndrome.

Microphthalmia VERY_FREQUENT HP:0000568

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis"

One of the seven cardinal findings.

Head and Neck 4

Recognizable facial features VERY_FREQUENT Abnormal facial shape HP:0001999

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis"

One of the seven cardinal findings; the facial gestalt is what the older name "dyscephalic syndrome" refers to.

Dental anomalies VERY_FREQUENT Abnormality of the dentition HP:0000164

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature"

One of the seven cardinal findings.

Micrognathia VERY_FREQUENT HP:0000347

Sequelae: Obstructive sleep apnoea

Show evidence (1 reference)

PMID:36405833 SUPPORT Human Clinical

"a rare congenital syndrome with different anomalies including midface hypoplasia, beak nose and micrognathia"

Micrognathia named among the defining craniofacial anomalies.

Midface hypoplasia VERY_FREQUENT Midface retrusion HP:0011800

Show evidence (1 reference)

PMID:36405833 SUPPORT Human Clinical

"different anomalies including midface hypoplasia, beak nose and micrognathia"

Midface hypoplasia named among the defining craniofacial anomalies.

Integument 3

Sparse hair with hypotrichosis VERY_FREQUENT HP:0008070

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"recognizable facial features, sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature"

One of the seven cardinal findings.

Skin atrophy VERY_FREQUENT Dermal atrophy HP:0004334

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature"

One of the seven cardinal findings.

Progeroid features OCCASIONAL Prematurely aged appearance HP:0007495

Show evidence (1 reference)

PMID:30580479 SUPPORT Human Clinical

"Clinically, patients with Hallermann-Streiff syndrome show typical craniofacial dysmorphism, eye malformations, a distinctive facial appearance, abnormalities of hair and skin, short stature, and, interestingly, they might also present with aspects of premature aging."

Names premature aging among the phenotypic traits; PARTIAL because the source presents it as a possible accompaniment rather than an expected finding.

Nervous System 1

Obstructive sleep apnoea FREQUENT Obstructive sleep apnea HP:0002870

Sequelae: Cor pulmonale

Show evidence (1 reference)

PMID:36405833 SUPPORT Human Clinical

"The upper airways narrowness can lead to severe respiratory complications such as obstructive sleep apnoea syndrome (OSAS), particularly in infancy."

States the mechanism and the age at which it matters most.

Growth 1

Short stature VERY_FREQUENT HP:0004322

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"skin atrophy, dental anomalies, and short stature"

The seventh cardinal finding.

Other 2

Natal teeth FREQUENT Natal tooth HP:0000695

Show evidence (1 reference)

PMID:36405833 SUPPORT Human Clinical

"She showed facial dysmorphic signs: tiny nose with marked nasal cartilage hypoplasia and skin atrophy, micro-retrognathy, microcephaly, neonatal teeth (51, 61, 71 and 81), bilateral congenital cataract, atrial septal defect and two small apical ventricular septal defects."

Names the four neonatal teeth by FDI position in a reported case.

Cor pulmonale OCCASIONAL HP:0001648

Show evidence (1 reference)

PMID:1776647 SUPPORT Human Clinical

"Upper airway obstruction may result from small nares and glossoptosis secondary to micrognathia, which sometimes lead to cor pulmonale."

States the full anatomical route from the craniofacial features to right heart failure, which is exactly how this phenotype is wired.

💊

Medical Actions

3

Non-Invasive Ventilation for Obstructive Sleep Apnoea

Action: non-invasive mechanical ventilation Ontology label: Non-Invasive Mechanical Ventilation NCIT:C171457

Management of HSS-related obstructive sleep apnoea is poorly documented, and tracheostomy has been the default when obstruction is severe. Non-invasive ventilation is the alternative worth trying first: in a reported infant with an obstructive apnoea-hypopnoea index of 140 per hour, for whom tracheostomy had been proposed, NIV was chosen after multidisciplinary discussion and succeeded. One case is not a guideline, but it is the best-documented airway option in a disorder where the airway is the main threat in infancy.

Target Phenotypes: Obstructive sleep apnea HP:0002870

Show evidence (2 references)

PMID:36405833 SUPPORT Human Clinical

"We report the case of an infant with HSS complicated by severe and early OSAS successfully managed with non-invasive ventilation (NIV)"

A single successful case. PARTIAL because one case cannot establish efficacy, which is also why the description says so.

PMID:36405833 SUPPORT Human Clinical

"The management of these severe OSAS is difficult and poorly documented in literature."

Establishes that no better-evidenced option exists, which is the context in which a single case report carries weight here.

Anaesthetic Airway Precautions

Action: Supportive Care NCIT:C15747

Recognizing the syndrome should itself change anaesthetic planning. Mandibular hypoplasia and microstomia make intubation difficult, and difficulty maintaining airway patency during induction has been reported. This is a safety instruction attached to any procedure requiring anaesthesia, not a treatment of the disorder.

Target Phenotypes: Micrognathia HP:0000347

Show evidence (2 references)

PMID:9136243 SUPPORT Human Clinical

"In the patients with Hallermann-Streiff Syndrome, presence of mandibular hypoplasia and microstomia results in difficult intubation."

States the anatomical basis of the anaesthetic risk.

PMID:9136243 SUPPORT Human Clinical

"Recognition of this syndrome should alert the physician to the possibility of difficulty in airway maintenance."

The actionable instruction this treatment entry records.

Multidisciplinary Craniofacial and Dental Reconstruction

Action: Surgical Procedure NCIT:C15329

Staged craniofacial and dental management across the growth period. A 20-year single-patient follow-up reports early genioplasty to improve facial growth and dental implantation before growth completion to provide orthodontic anchorage, with complementary orthognathic surgery. The evidence is one patient followed well, not a cohort.

Target Phenotypes: Abnormality of the dentition HP:0000164

Show evidence (1 reference)

PMID:29578805 SUPPORT Human Clinical

"early genioplasty and dental implantation before growth completion were performed. These steps allowed to improve facial growth and to provide orthodontic anchorage, respectively."

Describes the staged approach and its stated benefits. PARTIAL because it is a single patient, which the authors themselves frame as a proposal for consideration rather than an established modality.

🔬

Diagnosis

1

Clinical recognition of the facial gestalt and cardinal findings (Congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis, skin atrophy, dental anomalies and short stature)

The diagnosis is clinical, and it is clinical by default rather than by design: there is no genetic test and no biomarker, so recognition of the facial gestalt is all there is. This is the entry's weakest section for a real reason - the most recent review concludes the phenotype is consistent but that the label has probably collected heterogeneous conditions, so a confident gestalt-based diagnosis and an uncertain underlying entity coexist here. Osteocraniostenosis is the differential most worth excluding, since it is molecularly definable.

clinical evaluation NCIT:C124351

Show evidence (3 references)

PMID:30580479 SUPPORT Human Clinical

"The clinical diagnosis is mainly given by the very typical facial gestalt of patients."

States that gestalt recognition is the basis of diagnosis.

PMID:41742277 SUPPORT Human Clinical

"Hallermann-Streiff syndrome (HSS) is a rare genetic condition characterized by seven cardinal findings comprising congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature."

Enumerates the seven cardinal findings this record scores against.

PMID:41742277 SUPPORT Human Clinical

"the lack of a genetic test or other biomarker has complicated an accurate delineation of the condition"

The limitation that makes this a clinical diagnosis with no confirmatory test; PARTIAL because it qualifies the diagnostic approach rather than supporting it.

📊

Prevalence

2

Worldwide

Cases In Literature Not yet documented

Around 200 patients reported. No population rate has been published, and the absence of a genetic test means ascertainment is entirely clinical.

Show evidence (1 reference)

PMID:41742277 SUPPORT Human Clinical

"Around 200 patients have been reported and almost all cases have been sporadic."

Gives the reported case count and the sporadic occurrence pattern.

Japan

Point Prevalence 0.01 per 100,000 <1 in 1,000,000

Reported secondhand as approximately 1 in 10 million. This is the only numeric prevalence figure located for the disorder; note that it is cited rather than generated by the citing paper, and that ascertainment is entirely clinical since no genetic test exists.

Show evidence (1 reference)

PMID:36405833 SUPPORT Human Clinical

"A recent publication estimated its prevalence at 1/10 million in Japan"

The prevalence figure, reported as a citation of another publication rather than as this paper's own estimate - hence PARTIAL.

{ }

Source YAML

click to show

name: Hallermann-Streiff Syndrome
creation_date: "2026-08-27T04:30:00Z"
category: Mendelian
synonyms:
- HSS
- Francois dyscephalic syndrome
- Hallermann-Streiff-Francois syndrome
- oculomandibulodyscephaly with hypotrichosis
description: >-
  Hallermann-Streiff syndrome is defined by seven cardinal findings - congenital
  cataracts, microphthalmia, a recognizable facial gestalt, sparse hair with
  hypotrichosis, skin atrophy, dental anomalies and short stature. It is the
  outlier of its nosology group in a specific and important way: it is the only
  ISDS group-21 row with neither an inheritance mode nor a gene printed. About
  200 patients have been reported and almost all cases are sporadic, but no
  genetic test or biomarker exists, and the etiology of almost all cases remains
  unknown. Non-recurrent deleterious variants in GJA1, CHD6 and ZMPSTE24 have
  been noted in individuals diagnosed with HSS, none of them recurrent enough to
  constitute a molecular diagnosis.

  This entry is therefore deliberately mechanism-light. The pathophysiology
  section is a single node recording that the mechanism is unknown, and the
  entry does not import a candidate gene as if it were causal. A 2026 review
  makes the further point that the original reports probably described patients
  with heterogeneous conditions - so the diagnostic category may not correspond
  to a single disease at all. The differential includes osteocraniostenosis,
  which shares skull and long-bone anomalies but is usually lethal and adds the
  OCS facies and splenic hypoplasia that HSS lacks.
disease_term:
  preferred_term: Hallermann-Streiff syndrome
  term:
    id: MONDO:0009318
    label: Hallermann-Streiff syndrome
parents:
- Genetic disease
- Primordial dwarfism
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
  isds_skeletal_category:
  - classification_value: primordial_dwarfism_and_slender_bones
    notes: >-
      ISDS Nosology of Genetic Skeletal Disorders, 2023 revision (Unger et al.,
      PMID:36779427), group 21 "Primordial dwarfism and slender bone
      dysplasias", NOS 21-0070 "Hallermann-Streiff syndrome" (OMIM 234100). This
      is the only row in the group that prints neither an inheritance mode nor a
      gene - the committee lists the entity as clinically recognized but
      genetically unresolved. That is a statement about the nosology's inclusion
      criteria being clinical as well as molecular, and it is why this entry
      carries no causal gene.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: NOT_YET_DOCUMENTED
  notes: >-
    Around 200 patients reported. No population rate has been published, and the
    absence of a genetic test means ascertainment is entirely clinical.
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Around 200 patients have been reported and almost all cases have been sporadic."
    explanation: >-
      Gives the reported case count and the sporadic occurrence pattern.
- population: Japan
  measure_type: POINT_PREVALENCE
  prevalence_class: BELOW_1_IN_1000000
  rate_per_100000: 0.01
  notes: >-
    Reported secondhand as approximately 1 in 10 million. This is the only
    numeric prevalence figure located for the disorder; note that it is cited
    rather than generated by the citing paper, and that ascertainment is
    entirely clinical since no genetic test exists.
  evidence:
  - reference: PMID:36405833
    reference_title: "Long term NIV in an infant with Hallermann-Streiff syndrome: A case report and overview of respiratory morbidity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A recent publication estimated its prevalence at 1/10 million in Japan"
    explanation: >-
      The prevalence figure, reported as a citation of another publication
      rather than as this paper's own estimate - hence PARTIAL.
inheritance:
- name: Sporadic occurrence, inheritance unresolved
  description: >-
    Almost all reported cases are sporadic. No inheritance mode is established,
    and the ISDS Nosology prints none. A genetic basis is suspected but not
    demonstrated.
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Around 200 patients have been reported and almost all cases have been sporadic."
    explanation: >-
      Sporadic occurrence is what the literature reports; no mode of inheritance
      is asserted here because none is established.
pathophysiology:
- name: Unresolved Etiology
  biological_scale: ORGANISM
  role: trigger
  description: >-
    No mechanism is known. HSS is suspected to have a genetic basis, and
    non-recurrent deleterious variants in GJA1, CHD6 and ZMPSTE24 have been
    noted in individuals carrying the diagnosis, but none recurs across
    patients and the etiology of almost all cases remains unknown. There is no
    genetic test and no biomarker, which has itself hampered accurate
    delineation of the condition. This node exists to record the gap explicitly
    rather than to leave the pathophysiology section empty or to promote a
    candidate gene to a causal claim it cannot support.
  mechanism_confidence: HYPOTHETICAL
  downstream:
  - target: Congenital cataracts
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      One of the seven cardinal findings. Attached to the etiology node
      because no mechanism is known - the edge records that the feature
      belongs to the entity, not that a mechanism explains it.
  - target: Microphthalmia
    description: >-
      One of the seven cardinal findings; see the caveat on the cataract edge.
  - target: Recognizable facial features
    description: >-
      One of the seven cardinal findings; see the caveat on the cataract edge.
  - target: Sparse hair with hypotrichosis
    description: >-
      One of the seven cardinal findings; see the caveat on the cataract edge.
  - target: Skin atrophy
    description: >-
      One of the seven cardinal findings; see the caveat on the cataract edge.
  - target: Dental anomalies
    description: >-
      One of the seven cardinal findings; see the caveat on the cataract edge.
  - target: Short stature
    description: >-
      One of the seven cardinal findings, and what places the disorder in this
      nosology group; see the caveat on the cataract edge.
  - target: Micrognathia
    description: >-
      Part of the craniofacial gestalt, and the anatomical basis of the airway
      obstruction below.
  - target: Midface hypoplasia
    description: >-
      Part of the craniofacial gestalt, and with the micrognathia the
      anatomical basis of the airway obstruction.
  - target: Progeroid features
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Attached here on the same basis as the cardinal findings - the
      association is recognized, no mechanism is known. Worth noting that one
      of the three candidate genes named on this node, ZMPSTE24, causes
      laminopathies with premature aging, so the progeroid overlap is the
      feature that has most often motivated candidate-gene work.
  - target: Natal teeth
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      A specific instance of the dental anomalies already attached here; the
      same caveat applies - the edge records membership, not a mechanism.
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Although HSS is suspected to have a genetic basis and non-recurrent deleterious variants in genes such as GJA1, CHD6, and ZMPSTE24 have been noted in patients diagnosed with HSS, the etiology for almost all cases remains unknown."
    explanation: >-
      States both the candidate genes and the fact that they do not amount to an
      etiology, which is exactly the claim this node makes.
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the lack of a genetic test or other biomarker has complicated an accurate delineation of the condition"
    explanation: >-
      Explains why the entity itself, not just its mechanism, is imprecisely
      defined.
phenotypes:
- category: Ocular
  name: Congenital cataracts
  phenotype_term:
    preferred_term: Congenital cataract
    term:
      id: HP:0000519
      label: Developmental cataract
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "characterized by seven cardinal findings comprising congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature"
    explanation: >-
      One of the seven cardinal findings that define the syndrome.
- category: Ocular
  name: Microphthalmia
  phenotype_term:
    preferred_term: Microphthalmia
    term:
      id: HP:0000568
      label: Microphthalmia
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis"
    explanation: >-
      One of the seven cardinal findings.
- category: Craniofacial
  name: Recognizable facial features
  phenotype_term:
    preferred_term: Recognizable facial gestalt (dyscephaly)
    term:
      id: HP:0001999
      label: Abnormal facial shape
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis"
    explanation: >-
      One of the seven cardinal findings; the facial gestalt is what the older
      name "dyscephalic syndrome" refers to.
- category: Integumentary
  name: Sparse hair with hypotrichosis
  phenotype_term:
    preferred_term: Sparse hair
    term:
      id: HP:0008070
      label: Sparse hair
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "recognizable facial features, sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature"
    explanation: >-
      One of the seven cardinal findings.
- category: Integumentary
  name: Skin atrophy
  phenotype_term:
    preferred_term: Dermal atrophy
    term:
      id: HP:0004334
      label: Dermal atrophy
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature"
    explanation: >-
      One of the seven cardinal findings.
- category: Dental
  name: Dental anomalies
  phenotype_term:
    preferred_term: Abnormality of the dentition
    term:
      id: HP:0000164
      label: Abnormality of the dentition
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature"
    explanation: >-
      One of the seven cardinal findings.
- category: Growth
  name: Short stature
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  frequency: VERY_FREQUENT
  diagnostic: true
  description: >-
    The feature that places HSS among the primordial dwarfisms in the ISDS
    nosology.
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "skin atrophy, dental anomalies, and short stature"
    explanation: >-
      The seventh cardinal finding.
- category: Respiratory
  name: Obstructive sleep apnoea
  phenotype_term:
    preferred_term: Obstructive sleep apnea
    term:
      id: HP:0002870
      label: Obstructive sleep apnea
  frequency: FREQUENT
  sequelae:
  - target: Cor pulmonale
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Chronic upper-airway obstruction produces sustained hypoxaemia and
      pulmonary vasoconstriction, and the right heart fails under the load.
      The intermediate steps are standard cor pulmonale physiology rather than
      anything specific to this disorder, hence INDIRECT_KNOWN_INTERMEDIATES.
  description: >-
    The consequence of upper-airway narrowness from midface hypoplasia and
    micrognathia, and the respiratory issue that dominates infancy. It can be
    severe: one reported infant reached an obstructive apnoea-hypopnoea index of
    140 per hour with 41% of the night below 90% saturation.
  evidence:
  - reference: PMID:36405833
    reference_title: "Long term NIV in an infant with Hallermann-Streiff syndrome: A case report and overview of respiratory morbidity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The upper airways narrowness can lead to severe respiratory complications such as obstructive sleep apnoea syndrome (OSAS), particularly in infancy."
    explanation: >-
      States the mechanism and the age at which it matters most.
- category: Craniofacial
  name: Micrognathia
  sequelae:
  - target: Obstructive sleep apnoea
    description: >-
      Mandibular hypoplasia narrows the upper airway; with midface hypoplasia it
      is the anatomical cause of the obstructive apnoea.
  phenotype_term:
    preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  frequency: VERY_FREQUENT
  description: >-
    Together with midface hypoplasia, the anatomical basis of both the airway
    obstruction and the difficult intubation.
  evidence:
  - reference: PMID:36405833
    reference_title: "Long term NIV in an infant with Hallermann-Streiff syndrome: A case report and overview of respiratory morbidity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a rare congenital syndrome with different anomalies including midface hypoplasia, beak nose and micrognathia"
    explanation: >-
      Micrognathia named among the defining craniofacial anomalies.
- category: Craniofacial
  name: Midface hypoplasia
  phenotype_term:
    preferred_term: Midface retrusion
    term:
      id: HP:0011800
      label: Midface retrusion
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:36405833
    reference_title: "Long term NIV in an infant with Hallermann-Streiff syndrome: A case report and overview of respiratory morbidity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "different anomalies including midface hypoplasia, beak nose and micrognathia"
    explanation: >-
      Midface hypoplasia named among the defining craniofacial anomalies.
- category: Constitutional
  name: Progeroid features
  phenotype_term:
    preferred_term: Aspects of premature aging
    term:
      id: HP:0007495
      label: Prematurely aged appearance
  frequency: OCCASIONAL
  description: >-
    Reported as an accompanying feature rather than a cardinal one, and the
    reason HSS is repeatedly compared with the progeroid laminopathies. The
    source hedges ("might also present with"), so this is curated conservatively.
  evidence:
  - reference: PMID:30580479
    reference_title: "Hallermann-Streiff syndrome: A missing molecular link for a highly recognizable syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinically, patients with Hallermann-Streiff syndrome show typical craniofacial dysmorphism, eye malformations, a distinctive facial appearance, abnormalities of hair and skin, short stature, and, interestingly, they might also present with aspects of premature aging."
    explanation: >-
      Names premature aging among the phenotypic traits; PARTIAL because the
      source presents it as a possible accompaniment rather than an expected
      finding.
- category: Dental
  name: Natal teeth
  phenotype_term:
    preferred_term: Natal teeth
    term:
      id: HP:0000695
      label: Natal tooth
  frequency: FREQUENT
  description: >-
    A specific and unusual instance of the dental anomalies, and one of the
    features that makes the diagnosis recognizable at birth rather than later.
  evidence:
  - reference: PMID:36405833
    reference_title: "Long term NIV in an infant with Hallermann-Streiff syndrome: A case report and overview of respiratory morbidity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "She showed facial dysmorphic signs: tiny nose with marked nasal cartilage hypoplasia and skin atrophy, micro-retrognathy, microcephaly, neonatal teeth (51, 61, 71 and 81), bilateral congenital cataract, atrial septal defect and two small apical ventricular septal defects."
    explanation: >-
      Names the four neonatal teeth by FDI position in a reported case.
- category: Cardiovascular
  name: Cor pulmonale
  phenotype_term:
    preferred_term: Cor pulmonale
    term:
      id: HP:0001648
      label: Cor pulmonale
  frequency: OCCASIONAL
  description: >-
    Not a primary cardiac feature but the endpoint of untreated upper-airway
    obstruction: small nares and micrognathia-related glossoptosis produce
    chronic obstruction, and sustained obstruction loads the right heart. This
    is the pathway that makes respiratory death a real risk in infancy and the
    reason airway management is the priority in this disorder.
  evidence:
  - reference: PMID:1776647
    reference_title: "Respiratory obstruction and cor pulmonale in the Hallermann-Streiff syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Upper airway obstruction may result from small nares and glossoptosis secondary to micrognathia, which sometimes lead to cor pulmonale."
    explanation: >-
      States the full anatomical route from the craniofacial features to right
      heart failure, which is exactly how this phenotype is wired.
treatments:
- name: Non-Invasive Ventilation for Obstructive Sleep Apnoea
  description: >-
    Management of HSS-related obstructive sleep apnoea is poorly documented, and
    tracheostomy has been the default when obstruction is severe. Non-invasive
    ventilation is the alternative worth trying first: in a reported infant with
    an obstructive apnoea-hypopnoea index of 140 per hour, for whom tracheostomy
    had been proposed, NIV was chosen after multidisciplinary discussion and
    succeeded. One case is not a guideline, but it is the best-documented
    airway option in a disorder where the airway is the main threat in infancy.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: non-invasive mechanical ventilation
    term:
      id: NCIT:C171457
      label: Non-Invasive Mechanical Ventilation
  target_phenotypes:
  - preferred_term: Obstructive sleep apnea
    term:
      id: HP:0002870
      label: Obstructive sleep apnea
  evidence:
  - reference: PMID:36405833
    reference_title: "Long term NIV in an infant with Hallermann-Streiff syndrome: A case report and overview of respiratory morbidity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report the case of an infant with HSS complicated by severe and early OSAS successfully managed with non-invasive ventilation (NIV)"
    explanation: >-
      A single successful case. PARTIAL because one case cannot establish
      efficacy, which is also why the description says so.
  - reference: PMID:36405833
    reference_title: "Long term NIV in an infant with Hallermann-Streiff syndrome: A case report and overview of respiratory morbidity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The management of these severe OSAS is difficult and poorly documented in literature."
    explanation: >-
      Establishes that no better-evidenced option exists, which is the context
      in which a single case report carries weight here.
- name: Anaesthetic Airway Precautions
  description: >-
    Recognizing the syndrome should itself change anaesthetic planning.
    Mandibular hypoplasia and microstomia make intubation difficult, and
    difficulty maintaining airway patency during induction has been reported.
    This is a safety instruction attached to any procedure requiring anaesthesia,
    not a treatment of the disorder.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: PMID:9136243
    reference_title: "Hallermann-Streiff syndrome: airway problems during anaesthesia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In the patients with Hallermann-Streiff Syndrome, presence of mandibular hypoplasia and microstomia results in difficult intubation."
    explanation: >-
      States the anatomical basis of the anaesthetic risk.
  - reference: PMID:9136243
    reference_title: "Hallermann-Streiff syndrome: airway problems during anaesthesia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Recognition of this syndrome should alert the physician to the possibility of difficulty in airway maintenance."
    explanation: >-
      The actionable instruction this treatment entry records.
- name: Multidisciplinary Craniofacial and Dental Reconstruction
  description: >-
    Staged craniofacial and dental management across the growth period. A
    20-year single-patient follow-up reports early genioplasty to improve facial
    growth and dental implantation before growth completion to provide
    orthodontic anchorage, with complementary orthognathic surgery. The evidence
    is one patient followed well, not a cohort.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Surgical Procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_phenotypes:
  - preferred_term: Abnormality of the dentition
    term:
      id: HP:0000164
      label: Abnormality of the dentition
  evidence:
  - reference: PMID:29578805
    reference_title: "Diagnosis and Innovative Multidisciplinary Management of Hallermann-Streiff Syndrome: 20-Year Follow-Up of a Patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "early genioplasty and dental implantation before growth completion were performed. These steps allowed to improve facial growth and to provide orthodontic anchorage, respectively."
    explanation: >-
      Describes the staged approach and its stated benefits. PARTIAL because it
      is a single patient, which the authors themselves frame as a proposal for
      consideration rather than an established modality.
diagnosis:
- name: Clinical recognition of the facial gestalt and cardinal findings
  diagnosis_term:
    preferred_term: clinical evaluation
    term:
      id: NCIT:C124351
      label: Clinical Evaluation
  presence: Congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis, skin atrophy, dental anomalies and short stature
  description: >-
    The diagnosis is clinical, and it is clinical by default rather than by
    design: there is no genetic test and no biomarker, so recognition of the
    facial gestalt is all there is. This is the entry's weakest section for a
    real reason - the most recent review concludes the phenotype is consistent
    but that the label has probably collected heterogeneous conditions, so a
    confident gestalt-based diagnosis and an uncertain underlying entity
    coexist here. Osteocraniostenosis is the differential most worth excluding,
    since it is molecularly definable.
  evidence:
  - reference: PMID:30580479
    reference_title: "Hallermann-Streiff syndrome: A missing molecular link for a highly recognizable syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The clinical diagnosis is mainly given by the very typical facial gestalt of patients."
    explanation: >-
      States that gestalt recognition is the basis of diagnosis.
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Hallermann-Streiff syndrome (HSS) is a rare genetic condition characterized by seven cardinal findings comprising congenital cataracts, microphthalmia, recognizable facial features, sparse hair with hypotrichosis, skin atrophy, dental anomalies, and short stature."
    explanation: >-
      Enumerates the seven cardinal findings this record scores against.
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the lack of a genetic test or other biomarker has complicated an accurate delineation of the condition"
    explanation: >-
      The limitation that makes this a clinical diagnosis with no confirmatory
      test; PARTIAL because it qualifies the diagnostic approach rather than
      supporting it.
discussions:
- discussion_id: hss_entity_heterogeneity
  kind: KNOWLEDGE_GAP
  attaches_to:
  - pathophysiology#Unresolved Etiology
  prompt: >-
    Is Hallermann-Streiff syndrome one disease? If the original reports
    described patients with heterogeneous conditions, what fraction of the
    ~200 published cases would a molecular diagnosis reassign to some other
    entity?
  rationale: >-
    This is a gap about the entity, not only about its mechanism. A 2026 review
    concludes that the phenotype is consistent but that the original reports
    likely described heterogeneous conditions, and that HSS overlaps clinically
    with other genetic conditions - osteocraniostenosis among them. Without a
    genetic test, there is no way to tell a true HSS case from a phenocopy, so
    any mechanism curated for "HSS" risks being a mechanism for whatever mixture
    the label currently denotes.
  evidence:
  - reference: PMID:41742277
    reference_title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It is also likely that the original reports of HSS described patients with heterogeneous conditions."
    explanation: >-
      The review's own statement that the diagnostic category may not be a
      single entity.
references:
- reference: PMID:36405833
  title: "Long term NIV in an infant with Hallermann-Streiff syndrome: A case report and overview of respiratory morbidity."
- reference: PMID:9136243
  title: "Hallermann-Streiff syndrome: airway problems during anaesthesia."
- reference: PMID:29578805
  title: "Diagnosis and Innovative Multidisciplinary Management of Hallermann-Streiff Syndrome: 20-Year Follow-Up of a Patient."
- reference: PMID:41742277
  title: "A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions."
- reference: PMID:30580479
  title: "Hallermann-Streiff syndrome: A missing molecular link for a highly recognizable syndrome."
- reference: PMID:1776647
  title: "Respiratory obstruction and cor pulmonale in the Hallermann-Streiff syndrome."

📚

References & Deep Research

References

6

PMID:36405833

Long term NIV in an infant with Hallermann-Streiff syndrome: A case report and overview of respiratory morbidity.

No top-level findings curated for this source.

PMID:9136243

Hallermann-Streiff syndrome: airway problems during anaesthesia.

No top-level findings curated for this source.

PMID:29578805

Diagnosis and Innovative Multidisciplinary Management of Hallermann-Streiff Syndrome: 20-Year Follow-Up of a Patient.

No top-level findings curated for this source.

PMID:41742277

A review of Hallermann-Streiff syndrome demonstrates clinical overlap with other conditions.

No top-level findings curated for this source.

PMID:30580479

Hallermann-Streiff syndrome: A missing molecular link for a highly recognizable syndrome.

No top-level findings curated for this source.

PMID:1776647

Respiratory obstruction and cor pulmonale in the Hallermann-Streiff syndrome.

No top-level findings curated for this source.

Deep Research

1

Claude Code ▸

Hallermann-Streiff Syndrome: Comprehensive Research Report

claude-haiku-4-5-20251001, claude-sonnet-5 23 citations 2026-08-27T04:34:26.040787

Hallermann-Streiff Syndrome: Comprehensive Research Report

1. Disease Information

Overview. Hallermann-Streiff syndrome (HSS; also called Hallermann-Streiff-François syndrome, oculomandibulodyscephaly with hypotrichosis, or François dyscephalic syndrome) is an ultra-rare congenital dyscephalic syndrome first described by Aubry in 1893 and later characterized by Hallermann (1948) and Streiff (1950). It is defined by a recognizable constellation of craniofacial, ocular, dermatologic, dental, and growth abnormalities. A 2026 systematic review frames it as having seven cardinal findings: congenital cataracts, microphthalmia, recognizable "bird-like" facies, sparse hair (hypotrichosis), skin atrophy, dental anomalies, and proportionate short stature (Orphanet J Rare Dis, 2026, DOI 10.1186/s13023-026-04277-7).

Key identifiers: - OMIM: 234100 (omim.org/entry/234100) - Orphanet: ORPHA:2108 - MONDO: MONDO:0009318 - MedGen: UID 5414 / Concept ID C0018522 - SNOMED CT: 7903009 - Synonyms: François dyscephalic syndrome, Hallermann's syndrome, HSS, oculomandibulodyscephaly with hypotrichosis syndrome, Hallermann-Streiff-François syndrome

Data provenance. Because HSS has fewer than 200-250 reported cases worldwide, essentially all available data derive from aggregated case-report literature and systematic/scoping reviews (e.g., Cohen's 1991 review of 150 cases, PMID 1776643; a 1999 experience-with-15-patients review, PMID 10388418; and the 2026 Orphanet Journal of Rare Diseases review), not from large EHR cohorts or population registries — there is no disease-specific patient registry or biobank.

Sources: OMIM 234100, NORD, MedGen, Orphanet J Rare Dis 2026 review

2. Etiology

Causal factors. The molecular etiology of HSS is unresolved for the large majority of cases. Almost all reported cases are sporadic, and no recurrent causal gene has been established.

GJA1 (connexin 43, HGNC:4274): A homozygous missense variant (c.227G>A, p.R76H) was identified in a patient with an overlapping HSS/oculodentodigital dysplasia (ODDD) phenotype, with unaffected heterozygous-carrier parents (Pizzuti et al., Human Mutation 2004, "A homozygous GJA1 gene mutation causes a Hallermann-Streiff/ODDD spectrum phenotype," PMID reported as a companion to Paznekas et al. 2003, PMID 12457340 for the broader GJA1/ODDD mutation spectrum). ODDD itself is a dominant GJA1 (connexin 43 gap-junction) disorder; the HSS-overlap cases suggest recessive, hypomorphic GJA1 alleles can produce an HSS-like phenotype, but this remains atypical and not representative of most HSS cases.
CHD6 (chromodomain helicase DNA-binding protein 6): A de novo missense variant was identified in one patient with a clinical HSS diagnosis. Functional work in isogenic iPSC models (Klasic et al., Nature Communications 2021, DOI 10.1038/s41467-021-23327-1, PMC8140133) showed the mutation destabilizes CHD6 protein folding and impairs its ability to recruit chromatin co-remodelers upon DNA damage or autophagy stimulation, producing accumulated DNA damage and a senescence-like cellular phenotype — "a molecular mechanism explaining HSS onset via chromatin control of autophagic flux and genotoxic stress surveillance." This is a single-patient finding, not yet replicated as a recurrent HSS cause.
ZMPSTE24: Noted as a non-recurrent candidate variant in at least one patient, but a dedicated sequencing study of LMNA, ZMPSTE24, and ICMT in 8 HSS patients found no evidence that HSS is a laminopathy (Roos et al., Molecular Syndromology 2011, "Hallermann-Streiff Syndrome: No Evidence for a Link to Laminopathies" — explicitly ruling out mechanistic overlap with mandibuloacral dysplasia/progeroid laminopathies despite phenotypic resemblance).
Older hypotheses propose a defect in elastin metabolism or anomalous glycoprotein metabolism producing a developmental malformation in the 5th–6th week of gestation, but this is not molecularly confirmed.

Risk factors. No established genetic susceptibility loci, GWAS signals, or population risk-modifying variants exist for HSS given its extreme rarity and sporadic nature. Advanced parental age has been anecdotally proposed (consistent with a new-dominant-mutation model) but is not statistically established. No environmental, occupational, or infectious risk factor has been confirmed in humans.

Protective factors. None identified in the literature — not applicable to a presumed sporadic congenital malformation syndrome.

Gene-environment interactions. None documented for human disease. Notably, one search result flagged that the pesticide-related compounds retene and benzo[a]pyrene can induce an "HSS-like" craniofacial phenotype during zebrafish embryonic development — this is a teratogenic/toxicological phenocopy model, not evidence of a human gene-environment interaction, and should be treated cautiously as it does not establish causal human etiology.

Inheritance pattern debate. Orphanet and OMIM classify inheritance as "unknown" / "not generally inherited," and most cases are simplex/sporadic. However, a small number of multiplex/familial reports complicate this: - A three-generation family study (father → daughter → granddaughter, with skip in generation 4) documented apparent vertical transmission with variable expressivity, and the authors could not distinguish between autosomal dominant with variable expressivity, autosomal recessive, or recurrent new mutation (PMC5476608, PMID 28652825; citing foundational reviews PMID 1776643 [Cohen 1991] and PMID 15440024 [Streiff's original description]). - The GJA1-associated cases suggest an autosomal recessive mode is possible for at least a molecular subset. - Overall, most authorities describe HSS as sporadic/heterogeneous with an "ill-defined" inheritance pattern, and germline mosaicism/founder-effect data are not established.

Sources: Frontiers — Novel GJA1 variant, PubMed — GJA1/ODDD spectrum, PMID 14974090, Nature Communications — CHD6, Karger — No Evidence for Laminopathies, PMC5476608 — familial study, GARD

3. Phenotypes

The 2026 systematic review anchors diagnosis around seven cardinal findings plus a broader set of associated features. Frequencies below are drawn from aggregated case-series literature (primarily Cohen 1991, n=150, and subsequent reviews); most are qualitative/approximate given the small aggregate cohort.

Phenotype	Frequency (approx.)	HPO term (suggested)
Bilateral congenital cataract	>80% (near-universal)	HP:0000519 (Congenital cataract)
Microphthalmia	>80%	HP:0000568 (Microphthalmia)
Microcornea	Common	HP:0000482 (Microcornea)
Brachycephaly with frontal/parietal bossing	Very common	HP:0000248 (Brachycephaly); HP:0011220 (Frontal bossing)
"Bird-like" facies / beaked, thin, pinched nose	Characteristic, near-universal	HP:0000414 (Bulbous nose) / HP:0012810 (Thin nasal ala) — nearest available terms
Micrognathia / mandibular hypoplasia	Very common	HP:0000347 (Micrognathia)
Hypotrichosis (sparse scalp hair, may be patchy/localized)	Very common	HP:0000966 (Hypotrichosis)
Skin atrophy (esp. scalp and nose, taut/thin skin, telangiectasia)	Very common	HP:0007756 (Atrophic skin patches) / HP:0100585 (Telangiectasia)
Dental anomalies (natal/neonatal teeth, hypodontia/oligodontia, supernumerary teeth, enamel hypoplasia, malformed roots)	50–80%	HP:0000705 (Natal tooth); HP:0000668 (Hypodontia); HP:0006297 (Enamel hypoplasia)
Proportionate short stature	~50% (average adult height ~152 cm females, ~155 cm males)	HP:0003508 (Proportionate short stature)
Nystagmus / strabismus	10–30%	HP:0000639 (Nystagmus); HP:0000486 (Strabismus)
Blue sclerae	10–30%	HP:0000592 (Blue sclerae)
Glaucoma	Uncommon (isolated reports)	HP:0000501 (Glaucoma)
Upper airway obstruction / OSA / tracheomalacia	Over half of reported cases	HP:0002094 (Dyspnea) / HP:0002870 (Obstructive sleep apnea)
Intellectual disability / developmental delay	15–30% (minority; most have normal intelligence)	HP:0001249 (Intellectual disability)
Thin ribs/calvarium, scoliosis, joint hypermobility	Reported, variable	HP:0000926 (Scoliosis); HP:0001382 (Joint hypermobility)
Corneal perforation / exudative retinal detachment	Rare but reported (incl. monozygotic twins)	—
Lymphedema	Rare (case report)	HP:0001004 (Lymphedema)

Onset/severity/progression: All cardinal features are congenital — HSS is not described as a progressive degenerative disorder in the classic sense, though airway compromise and dental/ocular complications can worsen through infancy without intervention (e.g., escalating obstructive apnea-hypopnea index documented in a longitudinal NIV case, PMC9669373). Severity is highly variable even within families (a granddaughter met only 4/7 diagnostic criteria versus 6/7 in her father and mother, PMC5476608).

Quality of life impact: Chronic airway obstruction, poor sleep, and feeding difficulty in infancy drive the most severe QoL burden; visual impairment from cataracts/microphthalmia and social/psychological impact of dysmorphic facies are also documented (a specific psychological-findings-in-children study exists, PMID 1663704).

Sources: Orphanet J Rare Dis 2026 review, ScienceDirect systematic review 2026, NORD, PMC9669373 — NIV/respiratory morbidity, PMC10247501 — twins, corneal perforation

4. Genetic/Molecular Information

Causal genes: No single confirmed causal gene for the syndrome as classically defined. Candidate/non-recurrent genes reported in individual patients: GJA1 (HGNC:4274, connexin 43), CHD6, ZMPSTE24 (ruled out as a class — see laminopathy study above).
Variant classification/type: GJA1 case — homozygous missense p.R76H (c.227G>A) at a conserved residue, classified in the HSS/ODDD overlap spectrum; heterozygous parents were clinically unaffected, consistent with a recessive, hypomorphic effect at this residue (contrasting with the typical dominant ODDD-causing GJA1 missense mutations, e.g., L113P). CHD6 case — de novo missense variant, functionally shown to destabilize protein folding.
Functional consequences:
GJA1/connexin 43 — connexin 43 forms hexameric hemichannels assembling into gap junctions; the R76H hypomorphic allele is proposed to partially impair (rather than abolish) gap-junction function, distinguishing the recessive HSS/ODDD-overlap phenotype from dominant-negative ODDD alleles.
CHD6 — loss of proper chromatin-remodeler recruitment upon DNA-damage/autophagy signaling → accumulated DNA damage burden and cellular senescence, modeled in isogenic iPSC lines (Klasic et al. 2021).
Allele frequency/population data: Not applicable/not reported — these are private, non-recurrent variants found in single patients, not established in gnomAD/ExAC as recurrent pathogenic alleles for HSS.
Somatic vs. germline: All reported variants are germline (constitutional).
Modifier genes: None established.
Epigenetics: No DNA methylation/histone modification studies specific to HSS have been reported (distinct from the CHD6 mechanistic work, which concerns chromatin-remodeling protein function rather than an epigenetic mark per se).
Chromosomal abnormalities: No recurrent cytogenetic/CNV etiology has been established; HSS is not classically a microdeletion/microduplication syndrome.

Sources: Frontiers — GJA1 case report, PubMed 14974090, Nature Communications — CHD6, Karger — laminopathy exclusion

5. Environmental Information

No confirmed environmental, lifestyle, or infectious causal factors are established in humans. The single environmental-adjacent finding in the literature is a zebrafish teratogenicity study in which retene and benzo[a]pyrene exposure produced craniofacial phenocopies resembling HSS during embryonic development — this demonstrates a possible developmental-toxicology mechanism for HSS-like craniofacial dysmorphology in a model organism, but has not been linked to human HSS causation and should not be over-interpreted as an established human risk factor.

6. Mechanism / Pathophysiology

Mechanistic understanding of HSS is fragmentary, reflecting its largely unresolved genetic basis. Two partially distinct, non-mutually-validated mechanistic threads exist in the literature:

Developmental malformation hypothesis (classical): HSS is proposed to result from a defect in elastin metabolism or anomalous glycoprotein metabolism causing a developmental malformation during the 5th–6th week of gestation, affecting first- and second-branchial-arch-derived craniofacial structures (mandible, midface), the lens/anterior eye segment, and dermal/follicular structures (skin atrophy, hypotrichosis). This is a descriptive hypothesis from older literature without confirmed molecular support.
CHD6-chromatin/senescence hypothesis (molecular, single-patient-derived): In the one CHD6-variant patient studied mechanistically, isogenic iPSC modeling showed that the mutant CHD6 protein has impaired folding and fails to properly recruit chromatin co-remodeling machinery in response to DNA damage and autophagy stimulation. The downstream consequence is accumulation of DNA damage burden and a senescence-like cellular phenotype across differentiated cell types. The authors propose this represents "chromatin control of autophagic flux and genotoxic stress surveillance" as a candidate mechanism for at least a molecular subtype of HSS — potentially explaining the syndrome's progeroid-like features (skin atrophy, sparse hair) via a senescence-driven process, analogous to but molecularly distinct from classical laminopathies (which have been explicitly excluded, see above).

Causal chain (proposed, composite): Genetic/developmental insult (5th-6th week gestation) → disrupted craniofacial (branchial arch) and ocular (lens/globe) morphogenesis + connective tissue/dermal maldevelopment → structural phenotype at birth: micrognathia + midface hypoplasia + brachycephaly (craniofacial), congenital cataract + microphthalmia (ocular), skin atrophy + hypotrichosis (dermal), dental anomalies (odontogenic). Downstream/secondary consequences: micrognathia + glossoptosis + narrow nares + tracheomalacia → upper airway obstruction → obstructive sleep apnea → (if untreated) hypoxemia/hypercarbia → cor pulmonale and failure to thrive.

Suggested GO/CL/UBERON terms for pathophysiology modeling: - GO:0006281 (DNA repair) / GO:0006914 (autophagy) / GO:0090398 (cellular senescence) — for the CHD6 mechanistic thread - GO:0007507 (heart development)/branchial arch morphogenesis terms, GO:0043010 (camera-type eye development), GO:0043588 (skin development) - CL:0000362 (keratinocyte), CL:0000148 (lens fiber cell), CL:0000064 (ciliated columnar cell of tracheobronchial tree — relevant to airway) - UBERON:0001676 (mandible), UBERON:0000970 (eye), UBERON:0002073 (skin of scalp)

Immune system, metabolic, single-cell/spatial omics: No specific data identified in the literature for HSS.

Sources: Nature Communications — CHD6 mechanism, PMC8140133, Karger — laminopathy exclusion

7. Anatomical Structures Affected

Organ/system level: Craniofacial skeleton (skull, mandible, nose), eyes (globe, lens, cornea, sclera), integument (skin, hair follicles), dentition, skeletal system (ribs, calvarium, spine, joints), respiratory system (upper airway — secondary structural consequence), cardiovascular system (cor pulmonale secondary to chronic hypoxia), lymphatic system (rare lower-limb lymphedema case reported).
Tissue/cell level: Dermal/epidermal atrophy (thin, taut skin over scalp/nose with visible telangiectasia); hair follicle hypoplasia (hypotrichosis); lens epithelium (congenital cataract); corneal/scleral tissue (microcornea, blue sclerae); enamel/dentin-forming odontogenic tissue (enamel hypoplasia, malformed roots, natal teeth); cranial suture/membranous bone (brachycephaly, frontal bossing).
Subcellular level (from CHD6 mechanistic work): Nuclear chromatin-remodeling machinery, DNA damage response foci, autophagosome formation machinery.
Localization: Craniofacial anomalies are typically midline/bilateral (brachycephaly, bilateral cataracts, bilateral microphthalmia); skin atrophy is characteristically localized to the scalp and nose.

Suggested UBERON terms: UBERON:0001676 (mandible), UBERON:0000033 (head), UBERON:0000970 (eye), UBERON:0000151 (nose), UBERON:0002073 (skin of scalp), UBERON:0003128 (tooth).

8. Temporal Development

Onset: Congenital — all cardinal features are present at birth (some, like natal teeth, are literally present at delivery).
Onset pattern: Not applicable in the acute/insidious sense used for acquired disease; this is a structural congenital malformation syndrome.
Progression: Not a classically progressive/degenerative disease, but airway and ocular complications can worsen over infancy without intervention — documented longitudinally as escalating obstructive apnea-hypopnea index in one infant (from normal screening to OAHI of 140/h after adenoidectomy, later controlled to 7.6/h with BPAP; PMC9669373). Skin atrophy and craniofacial proportions are generally considered stable/non-worsening features once established, though this is not rigorously studied longitudinally.
Critical periods: Neonatal period and infancy represent the critical window for airway-related mortality risk; early childhood is critical for cataract surgery (to prevent amblyopia) and for management of erupted natal/deciduous teeth.
Disease course: Chronic, lifelong for surviving individuals; no remission pattern applicable (structural, not relapsing-remitting).

Sources: PMC9669373, ScienceDirect systematic review 2026

9. Inheritance and Population

Epidemiology: Fewer than ~200-250 cases reported worldwide in the literature to date. One Japanese publication estimated prevalence at ~1 per 10 million. No formal incidence/prevalence registry data exist; this is a literature-count-derived estimate, not a population-based epidemiological study.
Inheritance pattern: Predominantly sporadic, with inheritance classified by Orphanet/OMIM/GARD as "unknown"/ill-defined. A minority of familial reports (three-generation transmission) raise the possibility of autosomal dominant inheritance with variable expressivity in some families, while the GJA1-associated overlap cases suggest a recessive mechanism is possible for a molecular subset. No consensus mode of inheritance exists across the syndrome as a whole.
Penetrance/expressivity: Marked variable expressivity documented even within a single family (grandfather and daughter met 6/7 diagnostic criteria; granddaughter met only 4/7).
Genetic anticipation, germline mosaicism, founder effects, consanguinity, carrier frequency: None specifically established or reported in the literature reviewed; a consanguinity-associated recessive pattern has been hypothesized in some case reports but not statistically confirmed across the aggregate case series.
Population demographics: No ethnic/geographic predilection has been established; males and females are equally affected. Age distribution of affected individuals spans neonatal presentation through at least the seventh decade of life (a case diagnosed in the 7th decade has been reported), reflecting variable severity and diagnostic delay in milder cases.

Sources: GARD, NORD, PMC5476608, ScienceDirect — 7th decade diagnosis

10. Diagnostics

Clinical diagnostic criteria: Diagnosis is clinical, based on meeting a majority of the seven cardinal findings (congenital cataract, microphthalmia, characteristic facies, hypotrichosis, skin atrophy, dental anomalies, proportionate short stature); some literature uses this as an explicit scoring framework (e.g., "6 of 7 criteria met").

Laboratory tests/biomarkers: No disease-specific biochemical or serum biomarker exists.
Imaging: Skull radiography/CT classically shows brachycephaly, frontal/parietal bossing, hypoplastic mandible, thin calvarial bones; a reported case documented mid-diaphyseal endosteal thickening with medullary narrowing on long-bone imaging (PMC3279479). Prenatal ultrasound can detect micrognathia (e.g., via Inferior Facial Angle measurement, threshold ~50°) as an early red flag prompting further genetic workup, though this is nonspecific to HSS and shared with Pierre Robin sequence and other micrognathia-associated conditions.
Ophthalmic exam: Slit-lamp and B-scan ultrasound/OCT for cataract, microphthalmia, microcornea, retinal detachment risk assessment; ultrasound biomicroscopy has been used in atypical ocular presentations (PMC6919421).
Genetic testing: No validated targeted gene panel exists given the lack of a confirmed recurrent causal gene. Given case reports implicating GJA1 and CHD6, and exclusion of LMNA/ZMPSTE24/ICMT (laminopathy genes), a reasonable diagnostic approach is exome/genome sequencing (given genetic heterogeneity and mostly private variants) rather than a fixed panel; single-gene GJA1 testing may be considered when ODDD-overlap features (syndactyly, cleft palate) are present.
Electrophysiology: Polysomnography is important for airway/OSA assessment and monitoring (as in the BPAP case, PMC9669373).
Differential diagnosis: Key conditions to distinguish:
Oculodentodigital dysplasia (ODDD) — GJA1-related, dominant; overlapping ocular/dental features, distinguished by syndactyly/digital anomalies.
Mandibuloacral dysplasia (LMNA/ZMPSTE24-related laminopathy) — explicitly excluded as a mechanistic link for HSS despite phenotypic resemblance (progeroid facies, mandibular hypoplasia).
Progeria (Hutchinson-Gilford syndrome) — distinguished by early atherosclerosis, nail dystrophy, acromicria, chronic arthritis, and normal eyes (vs. HSS's defining ocular pathology).
Mandibulofacial dysostosis (Treacher Collins/Franceschetti syndrome), cleidocranial dysostosis, and other progeroid syndromes.
Cockayne syndrome — not specifically addressed in retrieved sources but commonly considered in progeroid-craniofacial differentials generally.
Screening: No population or newborn screening program exists; diagnosis is via clinical recognition, often prompted by prenatal micrognathia on ultrasound or postnatal recognition of the characteristic facies/cataracts.

Sources: PMC3279479 — skeletal imaging, PMC6919421 — ocular UBM/OCT, ScienceDirect — differential diagnosis

11. Outcome/Prognosis

Survival/mortality: No formal survival statistics exist due to rarity. Respiratory compromise is the principal cause of early mortality, particularly in the neonatal period and infancy, related to upper airway obstruction (small nares, glossoptosis from micrognathia, tracheomalacia) potentially progressing to cor pulmonale. One case-level observation cited an expected lifespan of ~47 years, but this is not a validated population statistic.
Morbidity: Chief morbidity drivers are obstructive sleep apnea (ranging mild to life-threatening), feeding difficulty/failure to thrive in infancy (secondary to airway obstruction and micrognathia), visual impairment from cataracts/microphthalmia if untreated, and dental complications (severe caries risk from enamel hypoplasia).
Complications: Cor pulmonale, iridocyclitis/glaucoma from retained cataractous lens material, corneal perforation (reported in a monozygotic twin case requiring keratoplasty), exudative retinal detachment, lymphedema (rare).
Recovery/functional outcome: With modern multidisciplinary airway management (including non-invasive ventilation and, when needed, mandibular distraction/tracheostomy) and early cataract surgery, many individuals survive into adulthood with normal or near-normal intelligence in the majority (70-85%) of cases.
Prognostic factors: Severity of airway/respiratory involvement is the single most important prognostic determinant; presence and degree of intellectual disability (minority of cases) also affects long-term functional outcome.

Sources: PMC9669373, PubMed 1776647 — cor pulmonale, PMC10247501 — twins with corneal perforation

12. Treatment

Management is multidisciplinary and supportive/symptomatic, since no disease-modifying or gene-targeted therapy exists.

Airway management (highest-priority in infancy):
Positioning, prone positioning, and monitoring for mild cases.
Non-invasive ventilation (BPAP) — a documented successful long-term approach for severe OSA (EPAP +5/IPAP +9 cmH2O improved obstructive AHI from 140/h to 7.6/h; PMC9669373). NCIT suggestion: NCIT:C15747 (Supportive Care) or a device-based intervention.
Mandibular distraction osteogenesis — used analogously to Pierre Robin sequence management to advance the mandible and relieve glossoptosis-related obstruction (NCIT:C15329, Surgical Procedure).
Tracheostomy for severe/refractory obstruction.
Anesthesia consultation strongly recommended before any elective procedure, given difficult intubation risk from micrognathia, microstomia, small nares, deviated septum, anterior larynx, and fragile natal teeth (avulsion risk during laryngoscopy).
Ophthalmologic:
Early cataract extraction recommended (despite reports of spontaneous cataract resorption in some cases) to prevent amblyopia and to reduce risk of iridocyclitis/glaucoma from a retained inflammatory lenticular/capsular nidus. Patients are often left aphakic due to severe microcornea/microphthalmia limiting IOL placement. NCIT:C15329 (Surgical Procedure)/relevant ophthalmic surgery term.
Monitoring for glaucoma, strabismus/nystagmus management, and retinal detachment surveillance.
Dental:
Preservation of prematurely erupted (natal/neonatal) deciduous teeth where feasible to support nutrition, pending confirmation of successional permanent teeth.
Comprehensive multidisciplinary dental management: preventive care (fluoride varnish, oral hygiene, dietary counseling), restorative care, oral-maxillofacial surgery, orthodontics, and prosthodontic reconstruction (including implants in select cases) — NCIT:C15302 (Physical Therapy)/NCIT dental-procedure equivalents are not precisely coded; general NCIT:C49236 (Therapeutic Procedure) applies.
Custom mouthguards for trauma protection given brittle/malformed dentition.
Craniofacial/orthopedic surgery: Reconstructive surgery of mandibular/nasal regions at appropriate developmental age; early genioplasty has been used to improve facial growth and provide orthodontic anchorage. NCIT:C16186 (Orthopedic Surgical Procedure).
Supportive/nutritional: Feeding support and monitoring for failure to thrive, particularly in infants with airway obstruction. NCIT:C15447 (Dietary Intervention).
Genetic counseling: Recommended given the debated inheritance pattern, particularly when familial recurrence or GJA1-overlap features (syndactyly) are present. NCIT:C15240 (Genetic Counseling).
Experimental/targeted therapy: None in clinical trials; no NCT-registered interventional trials specific to HSS were identified. The CHD6-senescence mechanistic finding is basic-science (iPSC modeling) and not yet translated to any therapeutic candidate.
Treatment outcomes: No systematic response-rate data exist; outcomes are reported at the individual case-series level (e.g., successful BPAP titration, successful multidisciplinary 20-year follow-up management reported in PMID 29578805).

Sources: PMC9669373, PubMed 25966733 — dental management, PubMed 29578805 — 20-year multidisciplinary follow-up, Frontiers — pulp calcifications case

13. Prevention

Primary prevention: Not applicable — HSS arises as a sporadic congenital malformation with no established modifiable environmental cause; no vaccination or risk-factor-modification strategy exists.
Secondary prevention (early detection): Prenatal ultrasound detection of micrognathia can prompt further genetic evaluation and delivery planning at a center equipped for high-risk neonatal airway management; early postnatal recognition of the cardinal facial/ocular gestalt enables prompt ophthalmologic and airway intervention.
Genetic counseling/screening: Recommended for families with a diagnosed case, particularly given the debated inheritance pattern and rare documented familial recurrence; no established carrier-screening or preimplantation genetic testing protocol exists given the lack of a confirmed recurrent causal gene for most cases.
Tertiary prevention: Proactive airway monitoring (polysomnography) and early cataract surgery function as tertiary prevention against downstream complications (cor pulmonale, amblyopia, glaucoma).
Public health: Not applicable given extreme rarity and non-infectious, non-environmentally-driven etiology.

14. Other Species / Natural Disease

No naturally occurring veterinary/companion-animal HSS analog was identified in the literature searched (no OMIA entry located). No confirmed orthologous animal disease exists.

15. Model Organisms

No validated genetic (knockout/knock-in/transgenic) animal model of HSS exists.
The closest available model-organism data are: (1) isogenic iPSC lines carrying the patient-derived CHD6 variant, used to study DNA-damage/autophagy/senescence phenotypes in vitro across differentiated cell types (Klasic et al. 2021, Nature Communications) — this is a cellular/genetic model, not a whole-organism model; (2) a zebrafish developmental-toxicology study in which retene/benzo[a]pyrene exposure produced craniofacial phenocopies resembling HSS — this is an induced/teratogenic phenocopy model, not a genetic model of the human disease, and its relevance to actual human HSS pathogenesis is unconfirmed.
Model limitations: No model recapitulates the full multi-system HSS phenotype (craniofacial + ocular + dermal + dental + growth); the iPSC model captures only cellular-level DNA-damage/senescence phenotypes relevant to a single-patient CHD6 variant, and the zebrafish toxicology model captures craniofacial dysmorphology via an environmental rather than genetic route.

Sources: Nature Communications — CHD6 iPSC model

Summary of Key Evidence Gaps

No confirmed recurrent causal gene — GJA1 and CHD6 are each supported by single/few-patient evidence only; most cases remain genetically unsolved.
Inheritance pattern remains unresolved — sporadic in the majority, but familial and GJA1-recessive evidence complicate a simple "not inherited" classification.
No whole-organism genetic animal model exists to validate proposed mechanisms (elastin/glycoprotein defect hypothesis vs. CHD6-senescence hypothesis) in vivo.
No population-based epidemiological data — prevalence estimates rest on literature case counts, not registry data.
No disease-modifying therapy — management is entirely supportive/surgical/symptomatic.

Sources (consolidated): - OMIM 234100 - Orphanet J Rare Dis 2026 review - ScienceDirect systematic review 2026 - NORD - GARD/NIH - MedGen - Frontiers — GJA1 case report - PubMed 14974090 — GJA1/HSS-ODDD - Nature Communications — CHD6 mechanism - Karger — laminopathy exclusion - PMC5476608 — three-generation familial study - PMC9669373 — respiratory morbidity/NIV case - PMC3279479 — skeletal imaging findings - PMC6919421 — ocular UBM/OCT case - PMC10247501 — monozygotic twins, corneal perforation - PubMed 25966733 — dental management - PubMed 29578805 — 20-year multidisciplinary follow-up - PubMed 1776647 — respiratory obstruction/cor pulmonale - EyeWiki

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	20
Resolved	20
Unresolved (possible confabulation)	0
Unverifiable	0
References weighed for topical relevance	20
On topic	8
Off topic	0

All extracted references resolved successfully.

Hallermann-Streiff Syndrome

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Medical Actions

Diagnosis

Prevalence

Source YAML

References & Deep Research

References

Deep Research

Hallermann-Streiff Syndrome: Comprehensive Research Report

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Summary of Key Evidence Gaps

Reference Validation